Flowchart of patients. by Seydou Goro (17847203)

“…Using the number of competitors per distance method, our study showed that a “highly competitive” and “moderately competitive” markets decreased mortality by 31% [OR: 0.69 (0.59, 0.80); p<0.001] and by 12% respectively [OR: 0.88 (0.79, 0.99); p<0.03], compared to the “non-competitive” market. …”

Proteins from FY26 EVs, CFT073 EVs, and CBE59 EVs identified with a label-free approach. by Min Jiang (56794)

The weighted UniFrac (A) and PCoA (B) analysis of bacterial samples in passion fruit rhizosphere soil. by Weiwei Lin (2442850)

Subjects:

Patient characteristics of individuals referred to or evaluated by a cystic fibrosis-gastrointestinal clinic. by Nicha Wongjarupong (4671181)

Table1_Decreased circulating omega-3 fatty acids increase the risk of myocardial infarction: a two-sample Mendelian randomization study.docx by Wei Wang (17594)

Binary and ordinal logistic regression analysis of predictors for the occurrence of ISR > 50%. by Jae-Chan Ryu (2850581)

Characteristics by group. by Arisa Kobayashi (4379608)

Subjects:

Kaplan–Meier curves for all-cause mortality. by Arisa Kobayashi (4379608)

Subjects:

Kaplan–Meier curve for mortality related to CVD. by Arisa Kobayashi (4379608)

Subjects:

Table 1_Increased intake of marine fish contributed to a decreased odds of comorbid depressive symptoms and coronary heart disease in Chinese adults.docx by Yuncao Fan (20573345)

“…The beneficial associations were pronounced with decreased odds of depressive symptom (OR: 0.31, 95% CI: 0.20, 0.47), but not with CHD (OR: 0.87, 95% CI: 0.59, 1.29).…”

DataSheet_1_Changing Trends in Melanoma Incidence and Decreasing Melanoma Mortality in Hungary Between 2011 and 2019: A Nationwide Epidemiological Study.docx by Gabriella Liszkay (10135301)

“…A 16.55% (95% CI: −27.07 to −4.59; p=0.013) decrease in mortality rates was found in the overall melanoma population.…”

Total viable immune cells and macrophages decrease acutely while neutrophils and macrophage increase at day 30 in parotid glands after 5Gy IR. by Jordan A. Gunning (18143970)

Detailed prevalence data from gnomAD [24] for ACE2 variants reported in Table 1. by Stuart A. MacGowan (11326845)

Subjects:

The structure of ACE2 (green) gnomAD [24] missense variant p.Lys26Arg that enhances Spike (light blue) binding affinity. by Stuart A. MacGowan (11326845)

Subjects:

Structural description of the ACE2 –Spike-protein interface. by Stuart A. MacGowan (11326845)

Subjects:

mCSM-PPI2 predicted ΔΔG with and without recalibration are in agreement with published deep mutagenesis binding data [22] at low predicted ΔΔG but recalibrated predictions are more... by Stuart A. MacGowan (11326845)

Subjects:

Estimated allele frequencies of potential novel variants in ACE2 with predicted Spike binding phenotypes. by Stuart A. MacGowan (11326845)

Subjects:

mCSM-PPI2 predictions for all gnomAD ACE2 missense variants in residues resolved in PDB 6vw1. by Stuart A. MacGowan (11326845)

Subjects:

Distribution of mCSM-PPI2 [13] predicted ΔΔG from in silico saturation mutagenesis of the ACE2-S interface in PDB 6vw1 [11]. by Stuart A. MacGowan (11326845)

Subjects:

A. mCSM-PPI2 predicted ΔΔG is linearly correlated with SPR determined ACE2 variant Spike RBD affinities for ACE2 variants with negative predicted ΔΔG. by Stuart A. MacGowan (11326845)

Subjects: